Companies:

 

Articles:

 

Stock summary

Companies:

 

Neuren Pharmaceuticals Limited (ASX: NEU)

 
Service provided by WebLinkIR

Company news

Cover Image for Neuren Pharmaceuticals to receive significant royalties on back of DAYBUE sales surge

Neuren Pharmaceuticals to receive significant royalties on back of DAYBUE sales surge

Cover Image for Tabcorp and Entain rumoured to bid for PointsBet, FDA approves Neuren’s Rett drug and IPH dives on cyber security breach

Tabcorp and Entain rumoured to bid for PointsBet, FDA approves Neuren’s Rett drug and IPH dives on cyber security breach

Cover Image for Neuren Pharmaceuticals receives FDA approval for world-first drug to treat Rett syndrome

Neuren Pharmaceuticals receives FDA approval for world-first drug to treat Rett syndrome

Cover Image for Neuren Pharma granted orphan drug status for treatment of Phelan-McDermid, Pitt Hopkins and Angelman syndromes

Neuren Pharma granted orphan drug status for treatment of Phelan-McDermid, Pitt Hopkins and Angelman syndromes